Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Digestive System Neoplasms × Docetaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 59 Carcinoma, Non-Small-Cell Lung 53 Stomach Neoplasms 28 Nasopharyngeal Carcinoma 21 Prostatic Neoplasms 18 Lung Neoplasms 17 Squamous Cell Carcinoma of Head and Neck 10 Esophageal Neoplasms 9 Neoplasm Metastasis 8 Head and Neck Neoplasms 6 Inflammatory Breast Neoplasms 4 HER2-positive Breast Cancer 4 Carcinoma, Squamous Cell 4 Triple Negative Breast Neoplasms 3 Sarcoma 3 Pancreatic Neoplasms 3 Nasopharyngeal Neoplasms 3 NSCLC 3 Esophageal Squamous Cell Carcinoma 3 Adenocarcinoma of Lung 3 Adenocarcinoma 3 Tongue Neoplasms 2 Squamous Cell Lung Cancer 2 Solid Tumor 2 Recurrence 2 Pain 2 Ovarian Neoplasms 2 Nonsquamous Non-Small Cell Lung Cancer 2 Neoplasms 2 Metastatic Castration-resistant Prostate Cancer 2

Interventions

Drug Therapy 3 Cisplatin 3 apatinib 2 anlotinib 2 Paclitaxel 2 Folfox protocol 2 Fluorouracil 2 Capecitabine 2 Bevacizumab 2 sintilimab 1 pyrotinib 1 pemigatinib 1 huachansu 1 Trastuzumab 1 Sorafenib 1 Radiotherapy 1 Physical Conditioning, Human 1 Oxaliplatin 1 Microspheres 1 Leucovorin 1 Irinotecan 1 Immune Checkpoint Inhibitors 1 Docetaxel 1 Chemoradiotherapy 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05262335 2023-11-28

ALTER-G-001

Ruijin Hospital

Phase 2 Unknown

Gastrointestinal

Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡